Pancreatic Cancer Research

ResearcherUniversity of TorontoActive in the last 2 years

Ahmed M. Elamir

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2908-3407; OpenAlex author ID A5016830325. Sources: OpenAlex.

Their work

Papers
7 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper · 2023: none · 2024: 1 paper · 2025: 3 papers

Papers 7

  1. Quality and Quantity: Dual Benefits of Ablative Radiation in Oligometastatic Pancreatic Cancer. First author DOI 10.1016/j.semradonc.2025.07.004↗
  2. Post-operative patterns of failure and outcomes reveal opportunities to optimize treatment of recurrent pancreatic cancer First author DOI 10.1101/2025.11.08.25339815↗
  3. Presurgical Ablative Radiation Is Associated with Local Control and Immune Response in Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-24-3582↗
  4. Delta Radiomic Features Predict Resection Margin Status and Overall Survival in Neoadjuvant-Treated Pancreatic Cancer Patients. Co-author DOI 10.1245/s10434-023-14805-5↗
  5. Ablative Radiation Therapy in Oligometastatic Pancreatic Cancer to Delay Polyprogression, Limit Chemotherapy, and Improve Outcomes. Co-author DOI 10.1016/j.ijrobp.2022.07.019↗
  6. A Risk Score Model for Locoregional Recurrence Following Upfront Surgery for Pancreatic Adenocarcinoma: Implications for Adjuvant Therapy. Co-author DOI 10.1016/j.clon.2021.03.007↗
  7. Simulated dose painting of hypoxic sub-volumes in pancreatic cancer stereotactic body radiotherapy. Co-author DOI 10.1088/1361-6560/ac215c↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Todd Anthony Aguilera · 5 shared papers, 2022–2025 · strength 1.13
  2. Patricio Marcelo Polanco · 4 shared papers, 2022–2025 · strength 0.70
  3. Herbert J. Zeh · 4 shared papers, 2022–2025 · strength 0.70
  4. Nina Niu Sanford · 3 shared papers, 2022–2025 · strength 0.54
  5. Syed Mohammad Ali Kazmi · 3 shared papers, 2022–2025 · strength 0.54
  6. Matthew R. Porembka · 3 shared papers, 2022–2025 · strength 0.54
  7. Ethan Bernard Ludmir · 1 shared paper, 2025 · strength 0.42
  8. Peter Q. Leung · 2 shared papers, 2025 · strength 0.41
  9. Salwan S. Al Mutar · 2 shared papers, 2025 · strength 0.41
  10. Adam Charles Yopp · 2 shared papers, 2024–2025 · strength 0.34
  11. Megan Wachsmann · 2 shared papers, 2024–2025 · strength 0.34
  12. Muhammad Shaalan Beg · 2 shared papers, 2022–2025 · strength 0.31
  13. John Michael P. Tomagan · 1 shared paper, 2025 · strength 0.23
  14. Shahed Nicolas Badiyan · 1 shared paper, 2025 · strength 0.23
  15. James D. Brierley · 2 shared papers, 2021 · strength 0.20
  16. Ali Hosni · 2 shared papers, 2021 · strength 0.20
  17. Grainne Mary O'Kane · 2 shared papers, 2021 · strength 0.20
  18. Jennifer Jane Knox · 2 shared papers, 2021 · strength 0.20
  19. Steve Gallinger · 2 shared papers, 2021 · strength 0.20
  20. Zhikai Chi · 1 shared paper, 2025 · strength 0.18
  21. Giovanni Luigi Capretti · 1 shared paper, 2024 · strength 0.16
  22. Iván Pedrosa · 1 shared paper, 2024 · strength 0.16
  23. Alessandro Zerbi · 1 shared paper, 2024 · strength 0.16
  24. Ravi Kiran Kaza · 1 shared paper, 2024 · strength 0.16
  25. Matteo Ligorio · 1 shared paper, 2024 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.